ClimoMW. Decreasing MRSA infections: An end met by unclear means. JAMA, 2009; 301:772–773.
2.
KallenAJ, MuY, BulensSet al.Active Bacterial Core Surveillance (ABCs) MRSA Investigators of the Emerging Infections Program. Health care-associated invasive MRSA infections, 2005–2008. JAMA, 2010; 304:641–648.
3.
ZilberbergMD, ShorrAF, KollefMH. Growth and geographic variation in hospitalizations with resistant infections, United States, 2000–2005. Emerg Infect Dis, 2008; 14:1756–1758.
4.
CalfeeDP, SalgadoCD, ClassenDet al.Strategies to prevent transmission of methicillin-resistant Staphylococcus aureus in acute care hospitals. Infect Control Hosp Epidemiol, 2008; 29:S62–S80.
5.
National Nosocomial Infections Surveillance (NNIS) System Report. Data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control, 2004; 32:470–485.
6.
ChabernyIF, SchwabF, ZiesingSet al.Impact of routine surgical ward and intensive care unit admission surveillance cultures on hospital-wide nosocomial methicillin-resistant Staphylococcus aureus infections in a university hospital: An interrupted time-series analysis. J Antimicrob Chemother, 2008; 62:1422–1429.
7.
RobicsekA, BeaumontJL, PauleSMet al.Universal surveillance for methicillin-resistant Staphylococcus aureus in 3 affiliated hospitals. Ann Intern Med, 2008; 148:409–418.
8.
HarbarthS, FankhauserC, SchrenzelJet al.Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA, 2008; 299:1149–1157.
9.
DiekemaDJ, ClimoM. Preventing MRSA infections: Finding it is not enough. JAMA, 2008; 299:1190–1192.
10.
WertheimHF, VosMC, OttAet al.Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet, 2004; 364:703–705.
11.
EllisMW, HospenthalDR, DooleyDPet al.Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis, 2004; 39:971–979.
12.
ByrnesMC, AdegboyegaT, RiggleAet al.Nasal swabs collected routinely to screen for colonization by methicillin-resistant Staphylococcus aureus in intensive care units are a sensitive screening test for the organism in clinical cultures. Surg Infect, 2010; 11:511–515.
13.
SarikondaKV, MicekST, DohertyJAet al.Methicillin-resistant Staphylococcus aureus (MRSA) nasal colonization is a poor predictor of ICU-acquired MRSA infections requiring antibiotic treatment. Crit Care Med(in press).
14.
SafdarN, BradleyEA. The risk of infection after nasal colonization with Staphylococcus aureus. Am J Med, 2008; 121:310–315.
15.
SakakiH, NishiokaM, KandaKet al.An investigation of the risk factors for infection with methicillin-resistant Staphylococcus aureus among patients in a neonatal intensive care unit. Am J Infect Control, 2009; 37:580–586.
16.
Von EiffC, BeckerK, MachkaKet al.Nasal carriage as a source of Staphylococcus aureus bacteremia. N Engl J Med, 2001; 344:11–16.
17.
Garrouste-OrgeasM, TimsitJF, KallelHet al.Colonization with methicillin-resistant Staphylococcus aureus in ICU patients: Morbidity, mortality, and glycopeptides use. Infect Control Hosp Epidemiol, 2001; 22:687–692.
18.
DavisKA, StewartJJ, CrouchHKet al.Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis, 2004; 39:776–782.
19.
CroftCA, MejiaVA, BarkerDEet al.Methicillin-resistant Staphylococcus aureus in a trauma population: Does colonization predict infection?Am Surg, 2009; 75:458–461.
20.
ChenAE, CanteyJB, CarrollKCet al.Discordance between Staphylococcus aureus nasal colonization and skin infections in children. Pediatr Infect Dis J, 2009; 28:244–246.
21.
SchweizerML, FurunoJP, HarrisADet al.Clinical utility of infection control documentation of prior methicillin-resistant Staphylococcus aureus colonization or infection for optimization of empirical antibiotic therapy. Infect Control Hosp Epidemiol, 2008; 29:972–974.
22.
PujolM, PenaC, PallaresRet al.Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am J Med, 1996; 100:509–516.
23.
CorbellaX, DominguezMA, PujolMet al.Staphylococcus aureus nasal carriage as a marker for subsequent staphylococcal infections in intensive care unit patients. Eur J Clin Microbiol Infect Dis, 1997; 16:351–357.
24.
SquierC, RihsJD, RisaKJet al.Staphylococcus aureus rectal carriage and its association with infections in patients in a surgical intensive care unit and a liver transplant unit. Infect Control Hosp Epidemiol, 2002; 23:495–501.
25.
FishbainJT, LeeJC, NguyenHDet al.Nosocomial transmission of methicillin-resistant Staphylococcus aureus: A blinded study to establish baseline acquisition rates. Infect Control Hosp Epidemiol, 2003; 24:415–421.
26.
PiarrouxR, GrenouilletF, BalvayPet al.Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients. Crit Care Med, 2004; 32:2443–2449.
27.
SegersP, SpeekenbrinkRG, UbbinkDTet al.Prevention of nosocomial infection in cardiac surgery by decontamination of the nasopharynx and oropharynx with chlorhexidine gluconate: A randomized controlled trial. JAMA, 2006; 296:2460–2466.
28.
KollefMH, PittetD, GarciaMSet al.A randomized double-blinded trial of iseganan in prevention of ventilator-associated pneumonia. Am J Respir Crit Care Med, 2006; 173:91–97.
29.
PerlTM, CullenJJ, WenzelRPet al.Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med, 2002; 346:1871–1877.
30.
ClimoMW, SepkowitzKA, ZuccottiGet al.The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: Results of a quasi-experimental multicenter trial. Crit Care Med, 2009; 37:1858–1865.
31.
KeeneA, LucianoL-F, LeviMet al.The use of a critical care consult team to identify risk for methicillin-resistant Staphylococcus aureus infection and the potential for early intervention: A pilot study. Crit Care Med, 2010; 38:109–113.
32.
JarlierV, TrystramD, Brun-BuissonCet al.Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program. Arch Intern Med, 2010; 170:552–559.
33.
KollefMH. Providing appropriate antimicrobial therapy in the intensive care unit: Surveillance vs. de-escalation. Crit Care Med, 2006; 34:903–905.
34.
EachempatiSR, HydoLJ, ShouJ, BariePS. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?J Trauma, 2009; 66:1343–1348.
